United States · Platforms & data · Finviz

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Published by Finviz · United States 21 h ago

Rapport Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing small molecule precision medicines for patients with neurological and…

Read the full article on Finviz Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finviz.com)

Also worth reading

MarketBeat

Oportun Financial (NASDAQ:OPRT) Sets New 12-Month High After Better-Than-Expected Earnings

MarketWatch

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Share

Also worth reading

Oportun Financial (NASDAQ:OPRT) Sets New 12-Month High After Better-Than-Expected Earnings

Big Tech’s $500 billion spending spree leaves a lot less for shareholders

ConocoPhillips Q3 preview: High expectations as upstream focus drives growth

Democrats win control of Congress as voters rebuke Trump agenda

Treasury yields fall after Democrats win House and Senate majorities

Best Stocks Under $5